C. difficile evades fluoroquinolones, cephalosporins and rampages

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1517, 2005-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging cephalosporins

By Page Malcolm GP  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 4, 2007-11 ,pp. : 511-524

Informa Healthcare

Access to resources Recommend Favorite

C. difficile-associated diarrhoea imposes high cost burden in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Progress in the Discovery of Treatments for C. difficile Infection: A Clinical and Medicinal Chemistry Review

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 1, 2014-01 ,pp. : 152-175

Bentham Science Publishers

Access to resources Recommend Favorite

C. difficile screening can be cost effective in US hospitals

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 659, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Fluoroquinolones in Paediatrics

By Gendrel D.   Moulin F.  

Pediatric Drugs, Vol. 3, Iss. 5, 2001-01 ,pp. : 365-377

Adis International

Access to resources Recommend Favorite